PR NewswirePress Release: Jazz Pharmaceuticals plc; Wake Up Narcolepsy – Thu, Mar 22, 2012 9:00 AM EDT
WASHINGTON and DUBLIN, March 22, 2012 /PRNewswire/ -- Wake Up Narcolepsy and Jazz Pharmaceuticals plc (Nasdaq: JAZZ - News) have teamed up with professional golfer, Nicole Jeray to launch the 2012 Swinging for Sleep online fundraising campaign. The campaign raises funds to support narcolepsy awareness, research and patient support programs through nonprofit organizations dedicated to the narcolepsy community.
To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/wake-up-narcolepsy-and-jazz-pharmaceuticals-announce-swinging-for-sleep-to-raise-funds-for-narcolepsy-awareness-143789786.html
"Narcolepsy is a neurological sleep disorder that often takes years to properly diagnose. Having battled this challenging condition for years, I understand first-hand the impact of the disease and how important it is to help others navigate living with it," said Nicole Jeray. "Swinging for Sleep is a great way for the narcolepsy community to come together to support the needs of patients and bring attention to this underdiagnosed condition."
Through Swinging for Sleep, Jazz Pharmaceuticals will donate $250 or $1000 for each "birdie" or "eagle" (low-swing scores on a single golf hole) respectively that Nicole Jeray scores during the 2012 LPGA Symetra Tour. Individuals are also encouraged to participate in the program by making a donation of their choice on Nicole's web site at www.nicolejeray.com. WUN will use proceeds raised by Swinging for Sleep to support awareness and research initiatives, including activities of another leading narcolepsy organization the Narcolepsy Network. Narcolepsy Network is a non-profit organization dedicated to providing services to educate, advocate, support and improve awareness of narcolepsy.
"Swinging for Sleep will support ongoing research and awareness activities to build a strong support system for patients, which is crucial to helping patients manage the disease," said Kevin Cosgrove, President, Wake Up Narcolepsy. "We commend Nicole Jeray for her dedication to the narcolepsy community and we are thrilled to be a part of the campaign and partnering with Jazz Pharmaceuticals."
Narcolepsy is a serious and debilitating sleep disorder that affects an estimated 125,000 to 200,000 Americans. Some people have narcolepsy for several years before being properly diagnosed. When left untreated, the symptoms can have a devastating effect on all aspects of one's life, emotionally, physically, socially and academically.
About Swinging for Sleep
Individuals are encouraged to support Swinging for Sleep in one of two ways – make a one-time donation, or pledge an amount for each birdie Jeray makes during the LPGA Symetra Tour in 2012. Nicole's success will be tracked on the Swinging for Sleep website: www.NicoleJeray.com/SwingingForSleep, and supporters should check here to follow her progress.
To learn more, visit www.WakeUpNarcolepsy.org or www.NicoleJeray.com.
Recent JAZZ News
- Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024 • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 03:38:33 PM
- Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024 • PR Newswire (US) • 09/09/2024 11:58:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:09:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2024 11:50:34 PM
- Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024 • PR Newswire (US) • 09/05/2024 11:30:00 AM
- Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/04/2024 04:12:00 AM
- Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/04/2024 04:00:00 AM
- Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/03/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 06:27:01 PM
- Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies • PR Newswire (US) • 08/22/2024 08:05:00 PM
- Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences • PR Newswire (US) • 08/21/2024 08:15:00 PM
- Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences • PR Newswire (US) • 08/21/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:45:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:42:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:42:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:40:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:40:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:39:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:39:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:53:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:52:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:50:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:48:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/06/2024 01:57:56 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM